These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20522078)

  • 1. A study investigating obstetricians' and gynaecologists' management of women requesting an intrauterine device.
    Black KI; Sakhaei T; Garland SM
    Aust N Z J Obstet Gynaecol; 2010 Apr; 50(2):184-8. PubMed ID: 20522078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection and performance of the levonorgestrel-releasing intrauterine system.
    Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J
    Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
    Wildemeersch D; Janssens D; Vrijens M; Weyers S
    Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey.
    Römer T; Linsberger D
    Eur J Contracept Reprod Health Care; 2009 Dec; 14(6):391-8. PubMed ID: 19929641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-hormonal and hormonal intrauterine contraception: survey of patients' perceptions in four Latin American countries.
    Silva-Filho AL; Lira J; Rocha AL; Ferreira MC; Lamaita RM; Cândido EB; Carneiro MM
    Eur J Contracept Reprod Health Care; 2016 Jun; 21(3):213-9. PubMed ID: 26848851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P; Lähteenmäki P; Rutanen EM
    Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of New Zealand RANZCOG Fellows on their use of the levonorgestrel intrauterine device in adolescents.
    Paterson H; Miller D; Devenish C
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):220-5. PubMed ID: 19432616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system.
    Bahamondes MV; Monteiro I; Castro S; Espejo-Arce X; Bahamondes L
    Hum Reprod; 2010 May; 25(5):1158-64. PubMed ID: 20185512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
    Rönnerdag M; Odlind V
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):716-21. PubMed ID: 10468065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The levonorgestrel intrauterine system in nulliparous women.
    Prager S; Darney PD
    Contraception; 2007 Jun; 75(6 Suppl):S12-5. PubMed ID: 17531602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine devices and intrauterine systems.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2008; 14(3):197-208. PubMed ID: 18400840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General practitioners' views on the use of the levonorgestrel-releasing intrauterine system in young, nulligravid women, in London, UK.
    Middleton AJ; Naish J; Singer N
    Eur J Contracept Reprod Health Care; 2011 Aug; 16(4):311-8. PubMed ID: 21585243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New frameless and framed intrauterine devices and systems - an overview.
    Wildemeersch D
    Contraception; 2007 Jun; 75(6 Suppl):S82-92. PubMed ID: 17531623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is gestagen IUD a realistic alternative to female sterilization?].
    Bjerge MR; Helm P
    Ugeskr Laeger; 2005 Jun; 167(25-31):2770-2. PubMed ID: 16014263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education.
    Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
    Contraception; 2014 Jun; 89(6):578-83. PubMed ID: 24656553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.